Physician profile
Jason M Kowitz
NPI 1346700986
$3,149.31
in general payments reported to CMS, 2019-2025
23 companies · $2,585 in 2025
The $2,585 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $564 · 2025: $2,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222 · Travel and Lodging: $577 · Consulting Fee: $250 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.93 |
| Travel and Lodging | $577.39 |
| Consulting Fee | $250.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,060.48 | 2025 | Altaviva, Interstim |
| Boston Scientific Corporation | $299.35 | 2025 | General - Kidney Stone Disease, Lithovue |
| Janssen Biotech, INC. | $277.88 | 2025 | Erleada |
| Ambu A/S | $250.00 | 2024 | |
| Conmed Corporation | $173.17 | 2024 | Airseal |
| Calyxo, INC. | $139.32 | 2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $138.51 | 2025 | Dornier Medtech |
| Dendreon Pharmaceuticals LLC | $107.01 | 2025 | Provenge |
| Teleflex LLC | $96.09 | 2025 | Urolift, Deknatel |
| Ferring Pharmaceuticals INC. | $95.16 | 2024-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $66.36 | 2025 | Keytruda Qlex, Keytruda, Lynparza |
| Olympus America INC. | $58.09 | 2025 | Soltive, Itind System |
| Urogen Pharma, INC. | $53.90 | 2024-2025 | |
| Abbvie INC. | $49.98 | 2024-2025 | |
| Immunitybio, INC. | $49.91 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $47.09 | 2025 | Xt Cdx |
| Baxter Healthcare | $36.06 | 2024 | Tisseel |
| Procept Biorobotics Corporation | $33.56 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.82 | 2024 | |
| Progenics Pharmaceuticals, INC. | $28.64 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.21 | 2025 | |
| 180 Medical, INC. | $20.56 | 2025 | Gentlecath Glide |
| Becton, Dickinson and Company | $17.16 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.